Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABM has commercialized seven FDA-cleared/CE-marked products used in over fifty clinical trials worldwide. Their technologies have demonstrated utility in objective diagnosis of sleep disorders and early detection of neurodegenerative disease using proprietary digital biomarkers. Eight clinically validated biomarkers are available for psychiatric/neurodegenerative conditions. Their mobile EEG systems are widely adopted by clinicians/researchers.[3]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Brain Monitoring.